ESC 365 - Implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy - A nationwide study

ESC Premium Access

Implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy - A nationwide study

Session: Risk of sudden death in hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor A. Tsangaris (Minneapolis, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Adamantios Tsangaris

University of Minnesota, Minneapolis (United States of America)

0 follower

4 more presentations in this session

Prevention of sudden death in HCM - State of the art

Speaker: Professor P. Elliott (London, GB)

Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study.

Speaker: Doctor G. Todiere (Pisa, IT)

An international validation study of the 2014 european society of cardiology sudden cardiac death risk prediction model in childhood hypertrophic cardiomyopathy

Speaker: Professor P. Elliott (London, GB)

Risk reduction in HCM: when the gradient is gone, do we still need an ICD?

Speaker: Doctor A. Rigopoulos (Marousi, Athens, GR)

Access the full session

Risk of sudden death in hypertrophic cardiomyopathy

Speakers: Doctor A. Tsangaris, Professor P. Elliott, Doctor G. Todiere, Professor P. Elliott, Doctor A. Rigopoulos

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources